IDH2 and central nervous system cancer: Patients with Ollier disease and Maffucci syndrome are at increased risk of developing IDH mutant gliomas in view of the underlying somatic IDH1/2 mutations (El Abiad et al., 2020; Pansuriya et al., 2011; Bonnet et al., 2016).